Compare IH & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IH | VANI |
|---|---|---|
| Founded | 1996 | 1998 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 82.8M | 95.8M |
| IPO Year | 2020 | 2014 |
| Metric | IH | VANI |
|---|---|---|
| Price | $1.75 | $1.49 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.50 |
| AVG Volume (30 Days) | 10.5K | ★ 266.9K |
| Earning Date | 03-31-2026 | 05-12-2026 |
| Dividend Yield | ★ 5.65% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $7.30 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.55 | $0.92 |
| 52 Week High | $3.60 | $1.92 |
| Indicator | IH | VANI |
|---|---|---|
| Relative Strength Index (RSI) | 51.21 | 74.55 |
| Support Level | $1.74 | $1.21 |
| Resistance Level | $2.29 | $1.55 |
| Average True Range (ATR) | 0.11 | 0.08 |
| MACD | 0.01 | 0.05 |
| Stochastic Oscillator | 78.57 | 98.19 |
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.